Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

10,694

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

10,694 results for “carcinoma,”

Learn how ShareScore rates datasets ↗
zenodo32/100

Immune Checkpoint Inhibitor, Nivolumab, Combined with Chemotherapy Improved the Survival of Unresectable Ad-vanced and Metastatic Esophageal Squamous Cell Carcinoma: a real world experience

<p><strong>Figure S1 the detail of treatments.</strong> Blue arrow means this patient was still alive at the latest date of follow up. Hollow circle means this patient die. The others were lose follow up at the latest date of follow up.</p> <p><strong>Figure S2 progression free survival (PFS) of patients received immunotherapy, including 5 nivolumab and chemotherapy and 1 dual immune check point inhibitor, on different PD-L1 tumor cells (TC) expression.</strong> (A) divided by PD-L1 TC &lt;1% or ≧1%. (B)divided by PD-L1 TC &lt;10% or ≧10%.</p>

opencc-by-4.0Mar 2023View details →
zenodo32/100

Predictive factors of large liver cell carcinoma tumor response after first conventional transarterial chemoembolization in Indonesia according to the modified response evaluation in solid tumors criteria: a preliminary study (supplemental data)

<p>Excel data of the above-mentioned research for supplemental purposes.&nbsp;&nbsp;</p>

opencc-by-4.0Apr 2023View details →
zenodo32/100

Mapping and modeling human colorectal carcinoma interactions with the tumor microenvironment

<p>This&nbsp;dataset&nbsp;can be interactively explored with VisCello (https://github.com/qinzhu/VisCello). Please install VisCello and use e.g.&nbsp;&quot;cello(&quot;path_to/hcc_main_cello&quot;)&quot; to load the human colon cancer single cell&nbsp;dataset.</p> <p>&nbsp;</p>

opencc-by-4.0Sep 2023View details →
zenodo32/100

A novel immune-related prognostic signature based on Chemoradiotherapy sensitivity predicts long-term survival in patients with esophageal squamous cell carcinoma.

<p>Raw Data for PeerJ</p>

opencc-by-4.0Jul 2023View details →
zenodo32/100

Gut microbiota as mediator and moderator between hepatitis B virus and hepatocellular carcinoma

<p>A STORMS (Strengthening The Organizing and Reporting of Microbiome Studies) checklist is available here.</p>

opencc-by-4.0Aug 2023View details →
zenodo32/100

Salivary chemical barrier proteins in Oral Squamous Cell Carcinoma – Alterations in the defense mechanism of the oral cavity

<p>Oral squamous cell carcinoma (OSCC) is one of the most frequent type of head and neck cancers. Despite the genetic and environmental risk factors, OSCC is also associated with microbial infections and/or dysbiosis. The secreted saliva serves as the chemical barrier of the oral cavity and since OSCC can alter the protein composition of saliva, our aim was to analyze the effect of OSCC on the salivary chemical barrier proteins. Publicly available datasets regarding the analysis of salivary proteins from patients with OSCC and controls were collected and examined in order to identify differentially expressed chemical barrier proteins. The network analysis and gene onthology (GO) classification of the differentially expressed chemical barrier proteins were performed, as well. 127 proteins showing different expression pattern between the OSCC and control groups were found. The protein-protein interaction network of up- and down-regulated proteins were constructed and analyzed. The main hub proteins (IL-6, IL-1B, IL-8, TNF, APOA1, APOA2, APOB, APOC3, APOE, and HP) were identified and the enriched GO terms were examined. Our study highlighted the importance of the chemical barrier of saliva in the development of OSCC.</p>

opencc-by-4.0Dec 2022View details →
zenodo32/100

High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints.

<p>Final Seurat file (rds) produced&nbsp;from the immune cell analysis&nbsp;performed in &quot;<strong>High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints</strong>.<em><strong>&quot;</strong></em></p>

opencc-by-4.0Dec 2022View details →
zenodo32/100

Nanostring PanCancer IO360 Data of Gastroenteropancreatic High-Grade Neuroendocrine Carcinoma

<p>Zip file includes raw RCC files used by Nanostring for data visualization of genomic information along with links to the Nanostring website where this data can be viewed in graphical format.&nbsp;</p>

opencc-by-4.0Sep 2023View details →
ClinicalTrials.gov32/100

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

ClinicalTrials.gov study NCT02907710. IPD Sharing: Not stated. Countries: 1. Publications: 7.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Cabozantinib in Advanced Adrenocortical Carcinoma

ClinicalTrials.gov study NCT03612232. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC)

ClinicalTrials.gov study NCT00618384. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife

ClinicalTrials.gov study NCT02363218. IPD Sharing: Not stated. Countries: 1. Publications: 16.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging

ClinicalTrials.gov study NCT01387503. IPD Sharing: Not stated. Countries: 1. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma

ClinicalTrials.gov study NCT04398056. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma

ClinicalTrials.gov study NCT04376866. IPD Sharing: NO. Countries: 1. Publications: 21.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Comparison Between High and Low Level Para-aortic Lymphadenectomy in High and Intermediate Risk Endometrial Carcinoma

ClinicalTrials.gov study NCT07306195. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

ClinicalTrials.gov study NCT06831175. IPD Sharing: NO. Countries: 1. Publications: 10.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma

ClinicalTrials.gov study NCT02859012. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

ClinicalTrials.gov study NCT07010692. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Diagnostic Accuracy of Optical Coherence Tomography in Upper Urinary Tract Urothelial Carcinoma

ClinicalTrials.gov study NCT02326909. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record